Seema Tevar

Statistics

Publications

Citations

1.1K

H-Index

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Seema Tevar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, enzyme inhibition, and aurora kinase inhibition.

Publications per year

2005–2010

Publications

ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTRand Sortilin

Henry Teng, Kenneth K. Teng, Ramee Lee et al. · Journal of Neuroscience · 2005 · 993 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure

Angela D. Kerekes, Sara Esposite, Ronald J. Doll et al. · Journal of Medicinal Chemistry · 2010 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core

Tao Yu, Jayaram R. Tagat, Angela D. Kerekes et al. · ACS Medicinal Chemistry Letters · 2010 · 35 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

SCH 2047069, a Novel Oral Kinesin Spindle Protein Inhibitor, Shows Single-Agent Antitumor Activity and Enhances the Efficacy of Chemotherapeutics

Andrea Basso, Ming Liu, Chaoyang Dai et al. · Molecular Cancer Therapeutics · 2010 · 19 citations

Medicine, Oncology, Pharmacology +15

Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors

David Belanger, Michael Williams, Patrick J. Curran et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

1–5 of 6